The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology

被引：121
|
作者：
Zauli, Giorgio
Secchiero, Paola
机构：
[1] Univ Trieste, Inst Normal Human Morphol, I-34138 Trieste, Italy
[2] Univ Ferrara, Dept Morphol & Embryol, I-44100 Ferrara, Italy
来源：
CYTOKINE & GROWTH FACTOR REVIEWS | 2006年 / 17卷 / 04期
关键词：
TRAIL; hematopoiesis; endothelial cells; TRAIL receptors; OPG;
D O I：
10.1016/j.cytogfr.2006.04.002
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
TRAIL is a member of the tumor necrosis factor superfamily that interacts with an unusually complex receptor system, comprising transmembrane (TRAIL-R1, -R2, -R3 and -R4) and soluble (osteoprotegerin) receptors. TRAIL has received considerable attention because of the finding that many cancer cell types are sensitive to TRAIL-induced apoptosis. However, increasing experimental evidence shows that TRAIL exhibits regulatory roles in various normal tissues, as well. Although the best-characterized biological activity of TRAIL is in the homeostatic regulation of the immune system, in this review we have summarized and discussed the physiological function of TRAIL and its receptors, in normal hematopoiesis and vascular physiopathology. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码：245 / 257
页数：13
相关论文
共 50 条
  • [21] Characterization of two receptors for TRAIL
    Schneider, P
    Bodmer, JL
    Thome, M
    Hofmann, K
    Holler, N
    Tschopp, J
    FEBS LETTERS, 1997, 416 (03) : 329 - 334
  • [22] Decoy receptors block TRAIL sensitivity at a supracellular level: the role of stromal cells in controlling tumour TRAIL sensitivity
    L O'Leary
    A M van der Sloot
    C R Reis
    S Deegan
    A E Ryan
    S P S Dhami
    L S Murillo
    R H Cool
    P Correa de Sampaio
    K Thompson
    G Murphy
    W J Quax
    L Serrano
    A Samali
    E Szegezdi
    Oncogene, 2016, 35 : 1261 - 1270
  • [23] Distinctive expression profiles of trail and trail receptors in patients with endometrial carcinoma
    Aydin, C.
    Bisgin, A.
    Sanlioglu, A. D.
    Pestereli, E.
    Erdogan, G.
    Ozbudak, I. H.
    Simsek, T.
    Sanlioglu, S.
    HUMAN GENE THERAPY, 2010, 21 (10) : 1462 - 1462
  • [24] Expression of trail receptors and antitumor effects of trail in human hepatocellular carcinoma
    Xiaoping, C
    Songqing, H
    JOURNAL OF HEPATOLOGY, 2003, 38 : 97 - 97
  • [25] Decoy receptors block TRAIL sensitivity at a supracellular level: the role of stromal cells in controlling tumour TRAIL sensitivity
    O'Leary, L.
    van der Sloot, A. M.
    Reis, C. R.
    Deegan, S.
    Ryan, A. E.
    Dhami, S. P. S.
    Murillo, L. S.
    Cool, R. H.
    de Sampaio, P. Correa
    Thompson, K.
    Murphy, G.
    Quax, W. J.
    Serrano, L.
    Samali, A.
    Szegezdi, E.
    ONCOGENE, 2016, 35 (10) : 1261 - 1270
  • [26] TRAIL Induces Nuclear Translocation and Chromatin Localization of TRAIL Death Receptors
    Mert, Ufuk
    Adawy, Alshaimaa
    Scharff, Elisabeth
    Teichmann, Pierre
    Willms, Anna
    Haselmann, Verena
    Colmorgen, Cynthia
    Lemke, Johannes
    von Karstedt, Silvia
    Fritsch, Juergen
    Trauzold, Anna
    CANCERS, 2019, 11 (08)
  • [27] CLINICAL SIGNIFICANCE OF TRAIL AND TRAIL RECEPTORS IN PATIENTS WITH HEAD AND NECK CANCER
    Yoldas, Burcak
    Ozer, Cem
    Ozen, Ozlem
    Canpolat, Tuba
    Dogan, Isilay
    Griffith, Thomas S.
    Sanlioglu, Salih
    Ozluoglu, Levent N.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2011, 33 (09): : 1278 - 1284
  • [28] Expression of TRAIL and TRAIL death receptors in stage III non-small cell lung cancer tumors
    Spierings, DCJ
    de Vries, EGE
    Timens, W
    Groen, HJM
    Boezen, HM
    de Jong, S
    CLINICAL CANCER RESEARCH, 2003, 9 (09) : 3397 - 3405
  • [29] Functional expression of TRAIL receptors TRAIL-R1 and TRAIL-R2 in esophageal adenocarcinoma
    Younes, M
    Georgakis, GV
    Rahmani, M
    Beer, D
    Younes, A
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (04) : 542 - 547
  • [30] TRAIL/TRAIL Receptor System and Susceptibility to Multiple Sclerosis
    Lopez-Gomez, Carlos
    Fernandez, Oscar
    Antonio Garcia-Leon, Juan
    Jesus Pinto-Medel, Maria
    Oliver-Martos, Begona
    Ortega-Pinazo, Jesus
    Suardiaz, Margarita
    Garcia-Trujillo, Lucia
    Guijarro-Castro, Cristina
    Benito-Leon, Julian
    Prat, Isidro
    Varade, Jezabel
    Alvarez-Lafuente, Roberto
    Urcelay, Elena
    Leyva, Laura
    PLOS ONE, 2011, 6 (07):
12345